Tissue Regenix Group plc (LON:TRX – Get Free Report)’s stock price traded down 2.8% during trading on Wednesday . The stock traded as low as GBX 59.80 ($0.74) and last traded at GBX 59.80 ($0.74). 44,239 shares changed hands during trading, a decline of 33% from the average session volume of 65,903 shares. The stock had previously closed at GBX 61.50 ($0.77).
Tissue Regenix Group Trading Down 2.8 %
The stock has a market capitalization of £42.20 million, a P/E ratio of -2,990.00 and a beta of 1.48. The firm’s 50 day moving average price is GBX 64.54 and its 200 day moving average price is GBX 58.26. The company has a debt-to-equity ratio of 32.01, a current ratio of 4.03 and a quick ratio of 2.36.
Tissue Regenix Group Company Profile
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally. The company operates through dCELL, BioRinse, and GBM-V segments. It also provides dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth.
Recommended Stories
- Five stocks we like better than Tissue Regenix Group
- 3 Small Caps With Big Return Potential
- United Airlines Soars on Earnings Beat
- What is Short Interest? How to Use It
- J.B. Hunt Hits the Skids: Lower Prices to Come
- What is the Dow Jones Industrial Average (DJIA)?
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.